NorthWest Biotherapeutics Inc (NWBO)

[bas2020]

I don't believe the MHRA delay is waiting for Eden. LP said previously that they will start with artisan (Advent) for initial production... and now they have IFR funding to accommodate and cover the initial lower-volume production and treatments. The new regulation #87, accommodating modular manufacturing, will enable Flaskworks introduction, which will also likely line up with NICE approval timing.